AU2008263507B2 - Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications - Google Patents

Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications

Info

Publication number
AU2008263507B2
AU2008263507B2 AU2008263507A AU2008263507A AU2008263507B2 AU 2008263507 B2 AU2008263507 B2 AU 2008263507B2 AU 2008263507 A AU2008263507 A AU 2008263507A AU 2008263507 A AU2008263507 A AU 2008263507A AU 2008263507 B2 AU2008263507 B2 AU 2008263507B2
Authority
AU
Australia
Prior art keywords
phoa
protein
hybrid protein
hybrid
alkaline phosphatase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008263507A
Other languages
English (en)
Other versions
AU2008263507A1 (en
Inventor
Hugues Bedouelle
Laetitia Bremand
Elodie Brient-Litzler
Philippe Despres
Philippe Dussart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Institut Pasteur
Original Assignee
Centre National de la Recherche Scientifique
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique, Institut Pasteur filed Critical Centre National de la Recherche Scientifique
Publication of AU2008263507A1 publication Critical patent/AU2008263507A1/en
Application granted granted Critical
Publication of AU2008263507B2 publication Critical patent/AU2008263507B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2008263507A 2007-06-15 2008-06-13 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications Ceased AU2008263507B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07290749.6 2007-06-15
EP07290749A EP2003144A1 (en) 2007-06-15 2007-06-15 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
PCT/IB2008/002614 WO2008152528A2 (en) 2007-06-15 2008-06-13 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications

Publications (2)

Publication Number Publication Date
AU2008263507A1 AU2008263507A1 (en) 2008-12-18
AU2008263507B2 true AU2008263507B2 (en) 2013-09-12

Family

ID=38740531

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008263507A Ceased AU2008263507B2 (en) 2007-06-15 2008-06-13 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications

Country Status (8)

Country Link
US (1) US8357496B2 (enExample)
EP (2) EP2003144A1 (enExample)
JP (1) JP2010530960A (enExample)
CN (1) CN101784561A (enExample)
AU (1) AU2008263507B2 (enExample)
BR (1) BRPI0814247A2 (enExample)
CA (1) CA2690764A1 (enExample)
WO (1) WO2008152528A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2272860A1 (en) 2009-07-10 2011-01-12 Institut Pasteur Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections
AU2010286368B2 (en) 2009-08-31 2015-09-03 Gen-Probe Incorporated Dengue virus assay
BR112015006497B1 (pt) * 2012-09-27 2023-01-17 Idexx Laboratories, Inc Método in vitro para identificar um animal não humano infectado com vírus schmallenberg (sbv), uso de um peptídeo ou uma mistura de peptídeos, e kit para a detecção de uma infecção por sbv em uma amostra
JP5866715B2 (ja) * 2013-10-18 2016-02-17 国立大学法人九州大学 タンパク質検出用融合タンパク質およびタンパク質の検出方法
EP3465206B1 (en) 2016-06-06 2019-12-04 Medizinische Universität Wien Method for the detection of an igm antibody specific for a flavivius in a sample
EP3558353A2 (en) * 2016-12-23 2019-10-30 Expres2ion Biotechnologies ApS New flavivirus vaccine
GB201704126D0 (en) * 2017-03-15 2017-04-26 Blom Nihlén Kim Andrea Vaccine
BR112019021872A2 (pt) * 2017-04-26 2020-06-02 F. Hoffmann-La Roche Ag Polipeptídeo, método de produção de um polipeptídeo, métodos para detectar anticorpos, usos de um polipeptídeo e kits de reagentes
CN108486219B (zh) * 2018-03-28 2022-02-25 中国人民解放军军事科学院军事医学研究院 一种检测离体血清样本是否感染乙型脑炎病毒的试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994020636A1 (en) * 1993-03-09 1994-09-15 Abbott Laboratories Genetically engineered enzymes and their conjugates for diagnostic assays
FR2736065B1 (fr) * 1995-06-29 1997-09-19 Commissariat Energie Atomique Phosphatases alcalines bacteriennes modifiees et leurs applications.
US7227011B2 (en) * 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
US7785799B2 (en) * 2002-08-16 2010-08-31 The Board Of Regents Of The University Of Texas System Compositions and methods related to flavivirus envelope protein domain III antigens
DE602005025647D1 (de) * 2004-07-23 2011-02-10 Novartis Vaccines & Diagnostic Polypeptide für die oligomerisierung von antigenen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEASLEY DAVID W C ET AL: "Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection." JOURNAL OF CLINICAL MICROBIOLOGY JUN 2004, vol. 42, no. 6, June 2004 (2004-06), pp 2759-2765 *
KERSCHBAUMER R J ET AL: "POAP2 : A VECTOR FOR CONSTRUCTION OF ALKALINE PHOSPHATASE FUSION- PROTEINS" IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, vol. 2, no. 2,1996, pages 145-150, *
LUOOLFS D ET AL: "Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans" EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, SPRINGER-VERLAG, BE, vol. 26, no. 7, 7 June 2007 (2007-06-07), pp 467-473 *

Also Published As

Publication number Publication date
WO2008152528A3 (en) 2009-03-12
US20100291586A1 (en) 2010-11-18
WO2008152528A2 (en) 2008-12-18
EP2170936A2 (en) 2010-04-07
JP2010530960A (ja) 2010-09-16
AU2008263507A1 (en) 2008-12-18
CN101784561A (zh) 2010-07-21
BRPI0814247A2 (pt) 2015-01-06
US8357496B2 (en) 2013-01-22
CA2690764A1 (en) 2008-12-18
EP2003144A1 (en) 2008-12-17

Similar Documents

Publication Publication Date Title
US8357496B2 (en) Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
Shi et al. Serologic diagnosis of West Nile virus infection
Gaspar-Castillo et al. Structural and immunological basis of cross-reactivity between dengue and Zika infections: Implications in serosurveillance in endemic regions
EP2272860A1 (en) Multivalent epitope in complex with a detection marker for the early serodiagnosis of infections
AnandaRao et al. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent
US11913953B2 (en) Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens
Kim et al. Development of a rapid diagnostic test kit to detect IgG/IgM antibody against Zika virus using monoclonal antibodies to the envelope and non-structural protein 1 of the virus
EP4185871A2 (en) System and methods for detection of pathogenic viruses
Kim et al. Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region
JP6908299B2 (ja) サンプル中のフラビウイルスに特異的なＩｇＭ抗体の検出方法
Niu et al. Dengue virus envelope domain III protein based on a tetravalent antigen secreted from insect cells: Potential use for serological diagnosis
EP1745291B1 (en) Detection of west nile virus
WO2007034507A2 (en) Tetravalent dengue specific domain iii based chimeric recombinant protein
Ludolfs et al. Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans
WO2005014627A1 (en) Recombinant dengue multi epitope proteins as diagnostic intermediates
Sjatha et al. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection‐enhancing antibody response
Malnero et al. Expression of recombinant dengue virus type 1 non-structural protein 1 in mammalian cells and preliminary assessment of its suitability to detect human IgG antibodies elicited by viral infection
Kim et al. Temperature-dependent secretion of Zika virus envelope and non-structural protein 1 in mammalian cells for clinical applications
US10921323B2 (en) Method for the immunological diagnosis of a sample with a potential infection with an arbovirus and test kits suitable for this purpose
Ma et al. Development of a sensitive sandwich ELISA for the envelope domain III protein of dengue virus type 2
Eltzov et al. Dengue virus diagnostics
Ganguly Ultrasensitive Point-of-Care Dengue Diagnostics and Vaccine Applications
WO2021236225A1 (en) Method for detection of zika virus specific antibodies
Loroño Pino et al. Characterization of epitope-blocking ELISA for differential diagnoses of secondary flavivirus infections
Pino Characterization of epitope-blocking ELISA for differential diagnoses of secondary flavivirus infections

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired